The E. coli pET expression system revisited—mechanistic correlation between glucose and lactose uptake by David Johannes Wurm et al.
BIOTECHNOLOGICAL PRODUCTS AND PROCESS ENGINEERING
The E. coli pET expression system revisited—mechanistic
correlation between glucose and lactose uptake
David Johannes Wurm1 & Lukas Veiter1 & Sophia Ulonska1 & Britta Eggenreich1,2 &
Christoph Herwig1,2 & Oliver Spadiut1,2
Received: 10 March 2016 /Revised: 1 May 2016 /Accepted: 7 May 2016 /Published online: 27 May 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Therapeutic monoclonal antibodies are mainly pro-
duced in mammalian cells to date. However, unglycosylated
antibody fragments can also be produced in the bacterium
Escherichia coliwhich brings several advantages, like growth
on cheap media and high productivity. One of the most pop-
ular E. coli strains for recombinant protein production is
E. coli BL21(DE3) which is usually used in combination with
the pET expression system. However, it is well known that
induction by isopropyl β-D-1-thiogalactopyranoside (IPTG)
stresses the cells and can lead to the formation of insoluble
inclusion bodies. In this study, we revisited the pET expres-
sion system for the production of a novel antibody single-
chain variable fragment (scFv) with the goal of maximizing
the amount of soluble product. Thus, we (1) investigated
whether lactose favors the recombinant production of soluble
scFv compared to IPTG, (2) investigated whether the forma-
tion of soluble product can be influenced by the specific glu-
cose uptake rate (qs,glu) during lactose induction, and (3)
determined the mechanistic correlation between the specific
lactose uptake rate (qs,lac) and qs,glu. We found that lactose
induction gave a much greater amount of soluble scFv
compared to IPTG, even when the growth rate was increased.
Furthermore, we showed that the production of soluble protein
could be tuned by varying qs,glu during lactose induction.
Finally, we established a simple model describing the
mechanistic correlation between qs,lac and qs,glu allowing
tailored feeding and prevention of sugar accumulation. We
believe that this mechanistic model might serve as platform
knowledge for E. coli.
Keywords Escherichia coliBL21(DE3) . pETexpression
system . Lactose induction . Antibody fragment . Soluble
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Introduction
Antibodies are used to treat a wide variety of human diseases.
More than 35 monoclonal antibodies and antibody fragments
have been commercialized, and around 240 therapeutic mono-
clonal antibodies and antibody fragments are in clinical trials
(Lee and Jeong 2015). Since more than 1000 kg of these
therapeutics are needed per year worldwide, there is an urge
for cheap and fast production (Elvin et al. 2013; Lee and Jeong
2015; Liu 2014; Rodrigues et al. 2010; Walsh 2014). Due to
the requirement of post-translational modifications, most ther-
apeutic monoclonal antibodies and antibody fragments are
produced in mammalian cells to date. However, there are
many drawbacks such as glycan heterogeneity, low volumet-
ric productivity, long cultivation times, expensive media, and
the potential risk of virus contamination (Khan 2013; Lee and
Jeong 2015). Thus, the prokaryotic organism Escherichia coli
has been investigated as alternative host for the production of
unglycosylated antibody fragments, mainly single-chain vari-
able fragments (scFv), which are also suitable for antigen de-
tection (Lee and Jeong 2015; Spadiut et al. 2014; Wals and
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Ovaa 2014). E. coli can be cultivated on inexpensive media to
high cell densities and has a high growth rate; its genetics are
very well characterized and an increasingly large number of
cloning vectors and mutant host strains are available (e.g.,
Baeshen et al. 2015; Rosano and Ceccarelli 2014). The
E. coli strain BL21(DE3) and its derivatives are by far the
most used E. coli strains for recombinant protein production
as they exhibit several biotechnological advantages compared
to other E. coli strains, such as low acetate yield, high biomass
yield, and reduced expression of proteases (Choi et al. 2006;
Ferrer-Miralles et al. 2015; Rosano and Ceccarelli 2014).
Usually, the well-known pET expression system is used in
combination with E. coli BL21(DE3) (Studier and Moffatt
1986). The lac operon can be induced by allolactose and its
molecular mimic isopropyl β-D-1-thiogalactopyranoside
(IPTG) (Neubauer et al. 1992). IPTG is a very strong inducer
that is not metabolized by E. coli, which is why one point
addition is sufficient. Thus, IPTG is usually used in industrial
production processes with E. coli BL21(DE3). However,
IPTG is known to put a high metabolic burden on the cells
resulting in the formation of inactive aggregates of the recom-
binant target protein, known as inclusion bodies (IBs). Thus,
lactose has been studied as alternative inducer. Lactose was
found to be as effective as IPTG, to increase cell fitness, to
reduce IB formation, and to enhance the formation of soluble
recombinant product (Bashir et al. 2015; Fruchtl et al. 2015;
Gombert and Kilikian 1998; Neubauer et al. 1992; Pei et al.
2011; Zou et al. 2014). However, lactose is metabolized by
E. coli making stable induction more complicated as it has to
be continuously supplied (Striedner et al. 2003). In a previous
study, it was nicely shown that lactose metabolism strongly
depends on the available amount of glucose (Kremling et al.
2015). However, a potential mechanistic correlation between
glucose and lactose uptake has not been investigated yet.
In this study, we used E. coli BL21(DE3) and the pET ex-
pression system for the production of a novel scFv (Stadlmann
et al. 2015). We hypothesized that induction by lactose in-
creases the amount of soluble product compared to IPTG.
Thus, we (1) tested and compared IPTG and lactose as inducer,
(2) investigated whether the formation of soluble product can
be influenced by the specific uptake rate of glucose during
induction with lactose, and (3) determined a mechanistic corre-
lation between the specific uptake rates of lactose and glucose.
Materials and methods
Strain
E. coli BL21(DE3) (Life technologies, Carlsbad, CA, USA)
and the pET28a(+) expression system were used for produc-
tion of the recombinant scFv which describes an engineered
IgY fragment against PT-gliadin useful for the treatment of
celiac disease (Stadlmann et al. 2015).
Bioreactor cultivations
Media
A defined minimal medium according to DeLisa et al. (1999)
supplemented with 0.02 g/L kanamycin and different amounts
of glucose and lactose (Table 1) was used for all cultivations.
Pre-culture
A 500-mL sterile DeLisa pre-culture medium were inoculated
from frozen stocks (1.5 mL, −80 °C) and incubated in a
2500-mL High-Yield shake flask in an Infors HR Multitron
shaker (Infors, Bottmingen, Switzerland) at 37 °C and
230 rpm for 20 h. Then a 4500-mL DeLisa-batch medium in
the bioreactor was inoculated with 500 mL of pre-culture.
Batch and fed-batch cultivations
Batch and fed-batch cultivations were done in a stainless steel
Satorius Biostat Cplus bioreactor (Satorius, Göttingen,
Germany) with a working volume of 10 L. The bioreactor
was aerated with a mixture of pressurized air and pure oxygen
at 1.5 vvm and agitated constantly at 1000 rpm. Dissolved
oxygen (dO2) was monitored with a fluorescence dissolved
oxygen electrode Visiferm DO425 (Hamilton, Reno, NV,
USA) and kept above 40 % throughout all cultivations by
varying the ratio of pressurized air to pure oxygen. pH was
monitored with an EasyFerm electrode (Hamilton, Reno, NV,
USA) and maintained constant at pH 7.2 by addition of
NH4OH (12.5 %). Base consumption was determined gravi-
metrically. CO2 and O2 concentrations in the off-gas were
monitored by a DASGIP GA gas analyzer (Eppendorf,
Hamburg, Germany). All process parameters were adjusted
and logged by the process information management system
Lucullus (Biospectra, Schlieren, Switzerland).
The batch phase was conducted at 35 °C and yielded a
biomass concentration of 8–9 g dry cell weight (DCW) per
liter. After depletion of glucose, visible by a drop in the CO2
off-gas signal, a fed-batch to generate a biomass was conduct-
ed. We fed at a constant specific glucose uptake rate (qs,glu) of
0.2 g/g/h. When the final DCW reached 25 g/L, the culture
Table 1 Sugar concentrations in different DeLisa media
Component Pre-culture Batch Feed glucose Feed lactose
C6H12O6·H2O (g/L) 8.8 22.0 275 –
C12H22O11·H2O (g/L) – – – 210
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was induced by IPTG or lactose, respectively. During non-
induced fed-batch and induction with IPTG, DCW in the bio-
reactor was estimated using a soft-sensor tool (Wechselberger
et al. 2013). During induction with lactose, DCW was calcu-
lated assuming a constant biomass yield (YX/S = 0.37 g/g, own
unpublished data). The feed rate was adjusted to maintain a
constant qs,glu and was calculated according to Eq. 1.




F Feed rate (g/h)
qs Specific substrate uptake rate (g/g/h)
X DCW concentration (g/L)
V Reactor volume (L)
W Amount of substrate per feed (g/g)
Cultivation strategy
In this study, cultivations following a standard procedure
comprising three phases (batch, non-induced fed-batch,
induced fed-batch) as well as dynamic experiments
(pulses and shifts) were carried out. Applying dynamic
process conditions to accelerate strain characterization
and bioprocess development is a common approach in
our working group (Dietzsch et al. 2011a, 2011b; Jazini
and Herwig 2011; Spadiut et al. 2013; Zalai et al. 2012).
An overview of the different cultivations and their respec-
tive goals is shown in Supplementary Table S1. Induction
was either performed by 0.5 mM IPTG or by lactose
which was applied either as pulses or by continuous feed-
ing. In these cultivations, the lactose concentration in the
media was kept in excess between 5 and 15 g/L.
Sampling
Samples were taken at the beginning and the end of the
batch and the non-induced fed-batch. During induction,
sampling was performed at the beginning and the end of
each shift/pulse and every hour during fed-batch cultiva-
tions. Specific product formation rates and final product
yields are given for an induction phase of approximately
4 h for all cultivations. DCW was determined by centrifu-
gation (4500g, 4 °C, 10 min) of 5 mL cultivation broth,
washing the obtained cell pellet with a 0.1 % NaCl solution
and subsequent drying at 105 °C for 48 h. Optical density at
600 nm (OD600) was measured in the photometer Genesys
20 (Thermo Scientific, Waltham, MA, USA). Samples were
diluted with deionized water to stay within the linear range
of the photometer (OD600 0.1–0.8). A linear correlation
between OD600 and DCW was established to verify and, if
necessary, correct the DCW estimation of the soft-sensor
(Eq. 2).
DCW ¼ OD600⋅0:445 ð2Þ
DCW Biomass dry cell weight (g/L)
OD600 Optical density at 600 nm
Substrate and metabolite quantification
Cell-free samples of the cultivation broth were analyzed for
concentrations of substrates and metabolites by HPLC
(Agilent Technologies, Santa Clara, CA, USA) with a
Supelcogel C-610 H ion exchange column (Sigma-Aldrich,
St. Louis, MO, USA) and a refractive index detector
(Agilent Technologies, Santa Clara, CA, USA). The mobile
phase was 0.1 % H3PO4 with a constant flow rate of 0.5 mL/
min, and the system was run isocratically at 30 °C.
Product quantification
Cells were harvested (4500g, 4 °C, 10 min), resuspended, and
diluted in Tris buffer (100 mM, 10 mM EDTA, pH 7.4) to a
DCW concentration of 5 g/L and subsequently homogenized
in an EmusiflexC3 Homgeniziser (Avestin, Ottowa, ON,
USA) at 1500 bar for five passages. After centrifugation (14,
000g, 4 °C, 10 min), soluble protein (SP) was recovered in the
supernatant and IBs in the pellet.
Cell debris from 0.5 mg DCW was resuspended in 1×
Laemmli buffer, and the supernatant was diluted with 2×
Laemmli buffer before the samples were heated at 95 °C for
10 min. Ten microliters of each sample were loaded onto pre-
cast SDS gels (8–16%) (GE Healthcare, Little Chalfont, UK).
Gels were run in an Amersham ECL Gel Box, a horizontal
mini-gel system (GE Healthcare, Little Chalfont, UK) for
90 min at 140 V and stained with Coomassie Blue. On every
gel, three BSA standards (0.5 μg, 1.5 μg, 3 μg per lane) were
applied. The protein bands were evaluated densitometrically
using the software Image Lab (Bio-Rad, Hercules, CA, USA).
Calibrations always gave an R2 above 0.96 and allowed the
quantification of SP and IBs. This method has been used
in over 700 publications to date and is known to give
precise data (e.g., Matusica et al. 2016; Wahlang et al. 2016;
Xu et al. 2016).
Results
In this study, we revisited the pETexpression system in E. coli
BL21(DE3) for the production of a novel scFv. We wanted to
(1) prove that lactose favors the recombinant production of
soluble scFv compared to IPTG, (2) investigate if the
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formation of soluble product can be influenced by qs,glu during
lactose induction, and (3) determine a mechanistic correlation
between qs,lac and qs,glu.
Induction by IPTG vs. lactose
We tested and compared IPTG and lactose as inducers for the
pET expression system. Slow uptake of glucose and thus a
low specific growth rate (μ) was described to result in higher
amount of SP (Shin et al. 1998). Thus, we wanted to investi-
gate whether this strategy was also suitable for the expression
of the novel scFv and conducted three fed-batch cultivations
with different qs,glu during induction with 0.5 mM IPTG
(Fig. 1a, Table 2).
At qs,glu of 0.45 g/g/h and 0.35 g/g/h only IBs were
formed during IPTG induction. IB formation decreased
when feeding at lower qs,glu. At qs,glu of 0.14 g/g/h,
soluble scFv was produced. Apparently the amount of
SP and IBs was strongly linked to qs,glu and thus μ.
Furthermore, by decreasing the feeding rate from qs,glu
0.45 to 0.14 g/g/h, the acetate formation rate was re-
duced more than 10-fold from 3.11 to 0.24 mg/g/h. It
is known that the formation of acetate has a negative
impact on cell growth and recombinant protein produc-
tion and should thus be kept at a minimum to ensure
high product quality (De Mey et al. 2007). Our findings
that a low μ leads to higher production of SP as well as
lower acetate formation are in good agreement with lit-
erature (Hellmuth et al. 1994; Sanden et al. 2005; Shin
et al. 1998). Nevertheless, more than half of the scFv
was still found as insoluble and inactive IBs. A further
decrease of qs,glu to potentially increase the amount of
SP was not feasible as it would have led to slow growth
and thus very long process times. Therefore, the alter-
native inducer lactose which is described to enhance cell
fitness and to increase the amount of SP (Donovan et al.
1996) was tested (Fig. 1b, Table 2). Even though qs,glu
was 0.30 g/g/h during lactose induction and thus more
than 2-fold higher than in the only experiment with
IPTG which gave SP (qs,glu = 0.14 g/g/h) around 30-
fold more soluble scFv was produced. Furthermore, the
acetate concentration was below the detection limit
when lactose was used as inducer (Table 2).
Tunability of recombinant protein production by varying
qs,glu during lactose induction
Furthermore, we investigated the potential tunability of re-
combinant protein production by testing three different qs,glu
during induction with lactose, which was always present in
excess (Fig. 2).
Figure 2 shows that both the formation of SP and IBs
strongly depended on qs,glu during lactose induction. There
was a clear optimum at qs,glu = 0.30 g/g/h. At qs,gluc of
0.06 g/g/h 14-fold less SPwas produced and also IB formation
was reduced 3-fold. We speculate that at this low qs,glu, the
cells basically only had enough energy for maintenance me-
tabolism but not for recombinant protein production.
However, we were rather surprised to see reduced production
of both SP and IB also at the higher qs,glu of 0.74 g/g/h. Thus,
we analyzed qs,lac at the respective qs,glu. As shown in Table 3,
qs,lac was strongly dependent on qs,glu. At qs,glu of 0.74 g/g/h,
only 0.02 g/g/h lactose were metabolized. We speculate that
this amount of inducer was too low to guarantee full induction,
thus resulting in reduced productivity.
Mechanistic correlation between qs,lac and qs,glu
Motivated by our observation of an apparent mechanistic cor-
relation between qs,lac and qs,glu (Table 3), we performed sev-
eral cultivations to shed more light on this physiological cor-
relation. First, we performed a batch cultivation with excess of
both glucose and lactose. In this experiment, we observed the
well-known phenomenon of carbon catabolite repression
(Stulke and Hillen 1999) meaning that as long as glucose
was present in excess , no lac tose was taken up
Fig. 1 a Specific product formation rate (qP) at different qs,glu during
IPTG induction. Black bars indicate specific production rate of
inclusion bodies (qP,IB), and gray bars specific production rate of
soluble product (qP,SP). b Specific product formation rate (qP) at
different qs,glu during IPTG or lactose induction. Black bars indicate
specific production rate of inclusion bodies (qP,IB), and gray bars
specific production rate of soluble product (qP,SP)
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(Supplementary Fig. S1). Only when glucose was depleted,
lactose was metabolized at a very slow rate of 0.05 g/g/h,
which is in agreement to literature (Kremling et al. 2015).
On the contrary, at limiting amounts of glucose but
an excess of lactose, we observed a much higher qs,lac
(Table 3). Several subsequent cultivations revealed that
qs,lac was in fact a function of qs,glu (Fig. 3, Table 4).
As shown in Fig. 3, qs,lac increased with increasing qs,
glu having a maximum at qs,glu of 0.2–0.25 g/g/h, before
it decreased again. We used these findings to generate a
simple mechanistic model describing qs,lac as a function
of qs,glu. Such a mechanistic model would greatly facil-
itate bioprocess development as only a few experiments
would be required to determine the correlation between
qs,lac and qs,glu. Thus, lactose accumulation and resulting
osmotic stress can be reduced (Shiloach and Fass 2005)
and tailored feeding and induction are possible. We hy-
pothesized that the correlation between qs,lac and qs,glu
was described by two phenomena, namely (1) qs,lac
depended Monod-like on qs,glu until a certain maximum
was reached, before (2) qs,lac decreased at high qs,glu
which was treated similarly to the phenomenon of sub-
strate inhibition (Sivakumar et al. 1994). To describe this
correlation, we adapted the model proposed by Han and
Levenspiel (1988) (Eq. 3).








qs;glu þ KA 1− qs;gluqs;glu;crit






qs,lac Specific lactose uptake rate (g/g/h)
qs,lac,max Maximum specific lactose uptake rate (g/g/h)
qs,glu Specific glucose uptake rate (g/g/h)
qs,glu,crit Critical specific glucose uptake rate up to which
lactose is consumed (g/g/h)
qs,lac,noglu Specific lactose uptake rate at qs,glu = 0 (g/g/h)
KA Affinity constant for the specific lactose uptake
rate (g/g/h)
m, n Type of inhibition (noncompetitive,
uncompetitive, competitive)
The unknown parameters in this model are the maximum
specific lactose uptake rate (qs,lac,max), the critical specific glu-
cose uptake rate up to which lactose is consumed (qs,glu,crit),
the affinity constant (KA), the two constants n and m indicat-
ing the type of inhibition (noncompetitive, uncompetitive,
competitive; (Han and Levenspiel 1988)) and the specific lac-
tose uptake rate at zero glucose uptake (qs,lac,noglu). For the
parameter identification, the Nelder-Mead simplex method
in MATLAB (Lagarias et al. 1998) was used to minimize
the objective function (Eq. 4) which describes the distance
between the experimental data and the predicted values by
the model. For points, where no standard deviation was avail-






























IPTG 0.45 0.16 0.62 0.059 0.00 3.11 0.006 2.50 0.00
IPTG 0.35 0.08 0.50 0.055 0.00 2.65 0.005 1.99 0.00
IPTG 0.14 0.03 0.44 0.046 0.34 0.036 0.24 0.001 1.76 1.37
Lactose 0.30 0.10 0.17 0.021 9.99 0.899 0.00 0.69 39.55
Fig. 2 Specific product formation rate (qP) at different qs,glu during
lactose induction. Black bars indicate specific production rate of
inclusion bodies (qP,IB), and gray bars specific production rate of
soluble product (qP,SP)
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qs,lac,meas,i ith measurement of qs,lac
qs,lac,model,i predicted qs,lac at timepoint of ith measurement
σi standard deviation of the ith data point
Based on our observations, we defined that qs,lac is greater
than zero when no glucose is consumed. Furthermore, param-
eter values must have a mechanistic meaning, which is why
we assumed qs,lac, KA, and n to be positive and even
constrained them further (e.g., qs,lac < qs,glu,crit, KA < 1,
n > 0, etc.). To analyze the model and to evaluate the impact
of the model parameters, we performed a sensitivity analysis,
where we increased or decreased the parameters by 20 % (an
example is shown in Supplementary Fig. S2).
The sensitivity analysis revealed the parameter m to have
almost no impact on the curve. Furthermore, the parameter
estimation revealed that this parameter is almost zero
(6.2 × 10−9). This is in accordance with our assumption of a
noncompetitive inhibition which is described by m = 0 (Han
and Levenspiel 1988). Thus, we set m to zero and simplified
the model (Eq. 5).













Additionally, the sensitivity analysis showed that n, qs,lac,
max,KA, qs,lac,noglu, and qs,glu,crit had a significant impact on the
curve. However, the impact of n was rather small and even a
potential error of 20 % would lead to only small deviations of
the curve (Supplementary Fig. S2). We used our experimental
data for the recombinant E. coli strain producing the novel
scFv and fitted the mechanistic model to the data using
Eq. 5. The curve with the estimated parameters fitted the data
with a normalized root mean square error (NRMSE) of 10.3%
and a coefficient of variation (CV) of 18.6 %. Furthermore, all
parameters showed physiologically reasonable values. The
resulting curve and the corresponding parameter values are
shown in Fig. 4 and Table 5, respectively.
Discussion
In this study, we used a pET expression system and an E. coli
BL21(DE3) strain for the production of a novel antibody
single-chain variable fragment. Since we wanted to maximize
the amount of soluble product and reduce the formation of
IBs, we (1) analyzed whether lactose favors the recombinant
production of soluble scFv compared to IPTG, (2) investigat-
ed whether the formation of soluble product can be influenced
by qs,glu during lactose induction, and (3) determined the
mechanistic correlation between qs,lac and qs,glu.
In fact, we showed that lactose allowed a much higher
production of soluble product compared to IPTG even when
μ was increased. This outcome is in good agreement not only
with several recent studies that also showed the benefits of
using lactose as inducer compared to IPTG for other recom-
binant products (Bashir et al. 2015; Fruchtl et al. 2015; Zou
et al. 2014) but also for antibody fragments (Donovan et al.
2000; Sanchez-Arreola et al. 2013). However, data on poten-
tial tunability of recombinant protein production by changing
qs,glu and thus μ during lactose induction are scarce to date.
Thus, we investigated a potential tunability of recombinant
protein production and found that the formation of soluble
product could be tuned by varying qs,glu during lactose induc-
tion. Furthermore, we observed a mechanistic correlation be-
tween qs,glu and qs,lac in these experiments which motivated us
to analyze this phenomenon in more detail.
In fact, we determined a mechanistic correlation be-
tween qs,lac and qs,glu and established a simple model.
Table 3 Strain physiological
parameters of E. coli BL21(DE3)
producing a scFv via a pET
expression system during lactose























Lactose 0.06 0.09 0.06 0.007 0.73 0.077 0.00 0.26 2.92
0.30 0.08 0.17 0.021 9.99 0.899 0.00 0.69 39.55
0.74 0.02 0.03 0.003 0.49 0.049 0.00 0.12 1.96
Fig. 3 qs,lac as a function of qs,glu for the recombinant E. coli strain
producing scFv with the pET expression system
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The shape of this curve can be explained by different
phenomena. At high qs,glu, no lactose is taken up which
can be explained by the phenomenon called carbon catab-
olite repression. When qs,glu decreases, cAMP gets formed
inside the cell. cAMP binds to the catabolite activator
protein (CAP) which undergoes a change in conformation
and binds to the promoter region of the lac operon.
Consequently, transcription of the lac operon’s genes in-
volving lactose permease and β-galactosidase is initiated
and lactose can be taken up. However, in the absence of
glucose, there is hardly any lactose taken up. The trans-
port of lactose into the cell is ATP related (Voet et al.
2010). Without glucose metabolism, basically no ATP is
generated, which is why this transport can barely happen
(Kremling et al. 2015; Luo et al. 2014; Mayer et al. 2014;
Siegal 2015).
The outcomes of this study can be used for strain
characterization and fast bioprocess development. The
values for the parameters qs,lac,noglu and qs,glu,crit, which
have a high impact on the curve, can be easily deter-
mined by simple batch cultivations. To determine the
other parameters (qs,lac,max, KA, and n), we recommend
performing two to three experiments where lactose is
provided in excess and qs,glu is adjusted to values below
qs,glu,crit. In the optimal case, one of these qs,glu values
corresponds to the maximum of qs,lac. However, if this
is not the case, qs,lac,max is simply underestimated, leav-
ing no risk for lactose accumulation. By performing
these few experiments, enough data can be gathered to
establish the mechanistic model. The mechanistic model
can then be used to interpolate unknown qs,lac values to
qs,glu points and thus allows fed-batch fermentations at
different qs,glu preventing unwanted lactose accumula-
tion. Furthermore, qs,lac can be adjusted within the fea-
sible range allowing to tune the production of soluble
protein, as we showed for the novel scFv (Table 3). By
this approach, the production of soluble and active pro-
tein can be significantly increased.
Summarizing this work emphasizes the applicability of lac-
tose, a cheap, nontoxic waste product, as inducer for the pro-
duction of soluble recombinant proteins in E. coli. In future
studies, wewill investigate if the mechanistic model established
in this study describes platform knowledge applicable to differ-
ent E. coli strains. We suggest that by performing two-batch
experiments and two to three fed-batches at different qs,glu and
concomitant lactose excess, enough data are available to fit the
model and obtain the mechanistic correlation for basically any
E. coli strain. Furthermore, we will test if induction by lactose
triggers expression on a cellular level or if E. coli subpopula-
tions are generated.
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Table 4 Experimentally evaluated qs,lac at respective qs,glu for the
recombinant E. coli strain producing scFv with the pET expression
system
qs,glu (g/g/h) Std. dev (g/g/h) qs,lac (g/g/h) Std. dev (g/g/h)
0.00 – 0.03 0.025
0.06 – 0.09 0.004
0.15 0.038 0.09 0.011
0.16 0.017 0.08 0.005
0.22 0.026 0.11 0.021
0.30 0.011 0.08 –
0.41 – 0.05 –
0.74 – 0.02 –
0.88 0.050 0.00 –
Fig. 4 Optimal fit with parameters qs, lac,max = 0.088 g/g/h,
qs,glu,crit = 0.88 g/g/h, qs,lac,noglu = 0.034 g/g/h, KA = 0.019 g/g/h, n = 1.16
Table 5 Parameters of optimal fit for the mechanistic correlation
between qs,lac and qs,glu for the recombinant E. coli strain producing
scFv with the pET expression system
qs,lac,max (g/g/h) qs,glu,crit (g/g/h) qs,lac,noglu (g/g/h) KA (g/g/h) n (−)
0.088 0.88 0.034 0.019 1.16
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